Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $159.0K | $327.0K | $526.0K | $360.0K | $3.8M | $14.0M | $22.1M | $43.1M |
| Cost of revenue | $0 | $319.0K | $308.0K | $248.0K | $2.8M | $8.8M | $21.8M | $40.5M |
| Gross profit | $159.0K | $8.0K | $218.0K | $112.0K | $948.0K | $5.2M | $317.0K | $2.6M |
| Gross margin | 100.0% | 2.4% | 41.4% | 31.1% | 25.1% | 37.0% | 1.4% | 6.0% |
| R&D | $858.0K | $0 | $0 | $0 | $1.1M | $682.0K | $849.0K | $1.1M |
| Operating income | −$5.1M | −$4.0M | −$3.8M | −$4.1M | −$20.7M | −$20.8M | −$43.5M | −$46.4M |
| EBITDA | −$5.0M | −$4.0M | −$3.8M | −$4.1M | −$19.0M | −$23.8M | −$42.9M | −$46.4M |
| Net income | −$5.1M | −$4.3M | −$4.1M | −$3.2M | −$22.3M | −$26.1M | −$43.8M | −$47.6M |
| Net margin | -3191.2% | -1327.5% | -771.5% | -895.3% | -590.5% | -187.1% | -198.0% | -110.5% |
| EPS (diluted) | -391.51 | -225.81 | -172.68 | -121.08 | -691.29 | -228.38 | -67.08 | -36.20 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds MDVL.
No tracked institution reports a position in MDVL as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-08-01 | 1-for-50reverse |
No one on the platform has traded MDVL yet.
| $3M |
| — |
| DMTKQDermTech, Inc. | $0.00 | +0.00% | $3496 | — |
| EIGRQEiger BioPharmaceuticals, Inc. | $8.50 | +6.25% | $13M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.